SCHEMBL2794308

SCHEMBL2794308

CCC(=O)c1ccc(Cl)c(Cl)c1S(=O)(=O)Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AB1 P08238 1/20 0.39
▸ CYP3A4 P08684 2/20 0.36
▸ CXCR2 P25025 1/20 0.35
▸ POLB P06746 1/20 0.33
▸ CHRNA7 P36544 3/20 0.33
▸ ALDH1A1 P00352 5/20 0.33
▸ LMNA P02545 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ TAS1R3 Q7RTX0 1/20 0.33
▸ TAS1R1 Q7RTX1 1/20 0.33
▸ TAS1R2 Q8TE23 1/20 0.33
▸ ATAD2 Q6PL18 1/20 0.32
▸ CYP2D6 P10635 2/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2791614 0.81 LMNA (0.35) CYP3A4CXCR2ALDH1A1LMNAKMT2A
SCHEMBL20501204 0.79 TSHR (0.47) POLBALDH1A1LMNAKDM4EMEN1
SCHEMBL28385050 0.78 HSP90AB1 (0.46) HSP90AB1CYP3A4POLBALDH1A1LMNA
SCHEMBL1260508 0.75 HSP90AB1 (0.47) HSP90AB1CYP3A4POLBALDH1A1KDM4E
SCHEMBL27537296 0.74 HSP90AB1 (0.42) HSP90AB1CYP3A4POLBALDH1A1LMNA
SCHEMBL1262272 0.71 PDE4D (0.43) HSP90AB1CYP3A4ALDH1A1KDM4ESMN1; SMN2
SCHEMBL27759983 0.70 ERCC5 (0.51) POLBCHRNA7ALDH1A1LMNAKDM4E
SCHEMBL2794495 0.70 ALDH1A1 (0.45) HSP90AB1CYP3A4POLBCHRNA7ALDH1A1
SCHEMBL24451116 0.69 HSP90AB1 (0.48) HSP90AB1CYP3A4POLBALDH1A1KDM4E
SCHEMBL9720563 0.69 HSP90AB1 (0.44) HSP90AB1CYP3A4POLBALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100168087-A1 BENZO[1,2,3]THIADIAZINE DERIVATES EGIS GYOGYSZERGYAR NYILVANOSAN MUKODO RESZVENYTARSASAG (HU) 2010-07-01 — — US disclosed
EP-2061777-A1 BENZOÝ1,2,3¨THIADIAZINE DERIVATIVES Egis Gyogyszergyar Nyilvánosan Múködó Részvénytársaság (HU) 2009-05-27 — — EP disclosed
WO-2008020255-A1 BENZO[1,2,3]THIADIAZINE DERIVATIVES EGIS GYÓGYSZERGYÁR Nyilvánosan Müködö Részvénytársagág (HU) 2008-02-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168087-A1 BENZO[1,2,3]THIADIAZINE DERIVATES SULT2A1, TPH1, CYP1A1 HSP90AB1 377/4885CYP3A4 171/4885CXCR2 3688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback